Acerta Pharma's Series B Round

Acerta Pharma raised a round of funding on May 01, 2015. Investors include T. Rowe Price.

Acerta Pharma, a privately-owned biotech company that combines two technology platforms in drug discovery and development: the Covalent Technology Platform and the Multiparametric Phosphoflow Cytometr…

Articles about Acerta Pharma's Series B Round: